BMP8B and metabolic dysfunction-associated steatotic liver disease: Based on these observations, we conclude that BMP8B can be used as a non-invasive predictive biomarker for NASH and recommend conducting more studies on BMP8B around the world to certify BMP8B as a non-invasive predictive biomarker in the field of NAFLD.